VAN ECK ASSOCIATES CORP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$820
+9.2%
21,477
+3.1%
0.00%0.0%
Q2 2023$751
-14.5%
20,823
-9.4%
0.00%0.0%
Q1 2023$878
-36.2%
22,983
-4.9%
0.00%
-50.0%
Q4 2022$1,376
-99.9%
24,177
-2.8%
0.00%
+33.3%
Q3 2022$983,000
-27.9%
24,868
-19.8%
0.00%
-25.0%
Q2 2022$1,364,000
-0.7%
30,992
-10.0%
0.00%
+33.3%
Q1 2022$1,374,000
+9060.0%
34,441
+2100.7%
0.00%
Q4 2016$15,000
+50.0%
1,565
+97.6%
0.00%
Q3 2016$10,000
+11.1%
792
-21.4%
0.00%
Q2 2016$9,0000.0%1,008
+10.6%
0.00%
Q1 2016$9,0009110.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders